Artificial Intelligence

Hamburg's Evocal Health scoops "Start-up Award - Digital Innovations"

28 April 2022
Start-up's AI identifies diseases based on biomarkers

The Hamburg-based Evocal Health has won the "Digital Innovations Start-up Prize" presented by the German Ministry of Economics and Climate Protection for its artificial intelligence. Dirk Simon, joint founder of Evocal Health accepted the prize in the health industry category during an online ceremony in April. The start-up's technology analyses changes in vocal biomarkers and detects diseases.

Detecting diseases with Innovative biomarker technology 

The award honours outstanding start-ups for a high degree of innovation, unique selling points, customer benefits, market potential and competitiveness. Simon commented: "Science and research have shown that a variety of diseases significantly change the physiology of the vocal systems and are barely audible to the human ear." The AI developed by Evocal Health searches the voice's audio signal for traits of a disease. As a result, the technology can be used to diagnose, monitor or to classify the severity of a disease.

Founded in 2021 by Philip Mertes and Simon, the company works with leading research institutions and health care providers and plans to open offices in Berlin and Munich in May 2022 and remains headquartered in Hamburg.

Sources and further information

Similar articles

Hamburg-based Procuros raises USD 9 million in seed funding

Start-up to put fresh capital towards automated, time-saving B2B processes

EUR 1.8 million in funds for research into 3D avatars in telemedicine

German government funds AI and mixed reality project managed by University of Hamburg

Hamburg's health care sector remains on growth course

Government releases latest figures - share of healthcare sector steadily increasing

Smoother airport operations thanks to artificial intelligence

Susan Wegner, Vice President AI & Data Analytics at Lufthansa Industry Solutions, discusses use of AI in aviation
The Consent Management Platform ( we use could not be loaded. This can happen if AdBlockers incorrectly block this URL. Some features such as maps, proximity search or forms, cannot be used this way. To use these features, please deactivate your AdBlocker or allow access to *